CDK4 and breast carcinoma: Cyclin D is also a target of TAZ in breast cancer stem cells and hippo/YAP/TAZ is a pathway promoting CDK4/6 resistance in breast cancer too, implying a global role of hippo/YAP/TAZ in cell cycle transition regulation [37,38].